United Therapeutics Corporation (UTHR) vs Zoetis Inc. (ZTS)
- United Therapeutics Corporation UTHR 533.12 −1.55%
- Zoetis Inc. ZTS 79.20 +0.99%
United Therapeutics Corporation and Zoetis Inc. are both Drug Manufacturers Specialty & Generic companies. Zoetis Inc. is the larger, with a market value of $32.4B against $23.2B — 1.4× the size. Zoetis Inc. trades at the lower P/E: 13.0× against 17.6×. United Therapeutics Corporation grew revenue faster over the last twelve months: 2.49% against 1.58%. United Therapeutics Corporation has the higher net margin (41.6% vs 27.7%) and the higher return on invested capital (23.4% vs 19.6%). Across the 22 metrics below, United Therapeutics Corporation leads on 13 and Zoetis Inc. on 9.
Valuation
Profitability
| Metric | UTHR | ZTS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 86.14% | 71.67% | 53.94% |
| Operating margin | 44.44% | 37.13% | 0.00% |
| Net margin | 41.56% | 27.69% | 0.00% |
| Free cash flow margin | 34.65% | 24.43% | 0.00% |
| Return on equity | 19.32% | 64.91% | (0.40%) |
| Return on assets | 17.33% | 17.84% | (3.32%) |
| Return on invested capital | 23.44% | 19.60% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack